Commercial Credit Report for Pharmena SA

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Pharmena SA is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Pharmena SA

ul. Wolczanska 178

Phone: +48 422913370p:+48 422913370

LODZ, 90-530 Poland

Ticker: PHRPHR

This company was Merged or Acquired on 12/27/2016.

This is a Subsidiary, click here for the Parent Company

Business Summary

Pharmena SA is a Poland-based producer of cosmetics and pharmaceuticals. The Company’s products range encompasses Dermena, a line of products against hair loss; Dermena Plus, a shampoo reducing the symptoms of dandruff and preventing excessive hair loss; Accos, an anti-acne gel; Allerco, a line of hypo-allergic emollients for body care, Thermi, a gel after thermal burn and sunburn; and Revium, a line of anti-wrinkle treatment products. Pharmena SA maintains multidirectional research works and application studies in conjunction with a number of research centers in Europe, the United States and Canada. As of December 31, 2011, the Company had one wholly owned subsidiary, Cortria Corporation, based in the United States. As of December 31, 2011, Polska Grupa Farmaceutyczna SA held a 43.65% stake in the capital. The main shareholder of the Company is Pelion SA.

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
Yes	Yes	-	-	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
12/31/2023	12/31/2023	Yes	-	-	-	-

Industries

SIC Code	Description
2844	Perfumes, cosmetics, and other toilet preparations
8731	Commercial physical and biological research

Officers and Directors

Title	Name	Title Date	Start Date
Chairman of the Management Board, Chief Executive Officer	KonradPalka
Vice Chairman of the Management Board, Director of Research and Development	MarzenaWieczorkowska	4/1/2008	4/1/2008
Chief Accounting Officer	KatarzynaKonopacka
5 additional Officers and Directors records available in full report.

Business Names

Business Name
Pharmena SA
PHR

General Information

Number of Employees:	15	(As of 12/31/2023)
Outstanding Shares:	11,137,758	(As of 12/31/2023)
Stock Exchange:	WAR
Fax Number:	+48 422913371

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN